Agenus announces promising trial results for colon cancer treatment at ESMO Congress

Agenus Inc. (Nasdaq: AGEN), a pioneer in the development of immunological agents for cancer treatment, has recently unveiled promising results from an investigator-sponsored trial (IST) ... Read More